Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RARX | BMY | AMGN | MRNA | GILD |
Company | Ra Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 47.99 | 52.58 | 270.00 | 104.98 | 73.69 |
High | 48.01 | 52.70 | 273.58 | 107.59 | 74.17 |
Low | 47.98 | 51.53 | 269.21 | 103.65 | 73.21 |
Last | 48.00 | 51.59 | 270.90 | 104.26 | 73.26 |
Change | -0.02 | -0.75 | +2.03 | +0.41 | -0.43 |
% Change | -0.03% | -1.43% | +0.76% | +0.39% | -0.58% |
Volume | 3,864,600 | 19,738,600 | 3,608,400 | 4,034,400 | 6,939,600 |
20-Day Average Volume | 1,869,975 | 20,320,305 | 3,167,750 | 4,652,420 | 7,194,110 |
Previous Close | 48.01 | 52.34 | 268.87 | 103.85 | 73.69 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 46.03 | 51.92 | 277.81 | 98.91 | 73.44 |
20-Day Raw Stochastic | 99.68% | 37.36% | 11.34% | 65.22% | 38.03% |
20-Day Relative Strength | 56.47% | 51.11% | 37.45% | 55.55% | 43.28% |
Weighted Alpha | +21.70 | -22.40 | +11.20 | -22.50 | -10.00 |
Today's Opinion | 56% Buy | 24% Sell | 8% Sell | 40% Buy | 88% Sell |
Previous Opinion | 56% Buy | 8% Sell | 8% Sell | 40% Buy | 72% Sell |
Last Month's Opinion | 80% Buy | 88% Sell | 56% Buy | 40% Sell | 40% Sell |
Performance | |||||
5-Days | |||||
%Chg | +0.91% since 03/25/20 | -5.10% since 03/11/24 | -1.62% since 03/11/24 | -6.89% since 03/11/24 | -2.73% since 03/11/24 |
Low | 46.34 on 03/26/20 | 51.53 on 03/18/24 | 268.17 on 03/15/24 | 100.94 on 03/15/24 | 73.21 on 03/18/24 |
High | 48.02 on 03/31/20 | 55.03 on 03/13/24 | 278.56 on 03/13/24 | 113.70 on 03/12/24 | 76.18 on 03/13/24 |
1-Month | |||||
%Chg | +2.64% since 02/28/20 | +3.47% since 02/16/24 | -4.51% since 02/16/24 | +17.98% since 02/16/24 | +2.35% since 02/16/24 |
Low | 40.30 on 03/18/20 | 49.53 on 02/21/24 | 268.17 on 03/15/24 | 85.53 on 02/21/24 | 71.45 on 02/20/24 |
High | 48.02 on 03/31/20 | 55.03 on 03/13/24 | 292.24 on 02/23/24 | 114.25 on 03/11/24 | 76.21 on 03/11/24 |
3-Month | |||||
%Chg | +2.27% since 12/31/19 | +0.49% since 12/18/23 | -1.66% since 12/18/23 | +22.06% since 12/18/23 | -7.85% since 12/18/23 |
Low | 40.30 on 03/18/20 | 47.58 on 02/06/24 | 268.17 on 03/15/24 | 84.06 on 02/13/24 | 71.37 on 02/16/24 |
High | 48.02 on 03/31/20 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
6-Month | |||||
%Chg | +112.27% since 10/01/19 | -11.93% since 09/18/23 | +2.95% since 09/18/23 | +0.12% since 09/18/23 | -3.12% since 09/18/23 |
Low | 22.25 on 10/08/19 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 71.37 on 02/16/24 |
High | 48.02 on 03/31/20 | 59.46 on 09/21/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
Key Statistics | |||||
Market Capitalization, $K | 2,271,555 | 105,841,584 | 144,092,544 | 39,678,280 | 91,801,160 |
Shares Outstanding, K | 47,329 | 2,022,193 | 535,919 | 382,073 | 1,245,775 |
Annual Sales | 3,000,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
Annual Net Income | -102,690,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
Last Quarter Sales | 3,000,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
Last Quarter Net Income | -24,980,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
60-Month Beta | 1.04 | 0.38 | 0.58 | 1.60 | 0.18 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
Latest Earnings Date | 05/14/20 | 04/25/24 | 04/25/24 | 05/02/24 | 04/25/24 |
Most Recent Dividend | N/A | 0.600 on 01/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 7.00 | 14.56 | 0.00 | 11.04 |